Ekso Bionics Provides COVID-19 Business Update and Reports Preliminary First Quarter 2020 Financial Results
Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ:AMEX Investor Relations:
ir.eksobionics.com
Company Research
Source: GlobeNewswire
- Company Regains Nasdaq Listing Compliance - RICHMOND, Calif., April 09, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary financial results for the first quarter ended March 31, 2020 and provided an update on the impact of the COVID-19 pandemic on its business activities. In addition, the Company confirmed that as of April 7, 2020, it has regained compliance with the minimum bid price requirement required by the listing rules of the Nasdaq Capital Market. The COVID-19 pandemic impacted Ekso Bionics' business in the first quarter as its customers shifted their priorities to prepare for and manage their business during the pandemic. This has caused many of its customers to delay orders, which are typically booked in the last few weeks of a quarter. It is important to note that a majority of the Company’s customers have indicated that their originally plan
Show less
Read more
Impact Snapshot
Event Time:
EKSO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EKSO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EKSO alerts
High impacting Ekso Bionics Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
EKSO
News
- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) had its price target raised by analysts at HC Wainwright from $9.25 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Ekso Bionics Announces First Quarter 2024 Financial ResultsGlobeNewswire
- Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024 [Yahoo! Finance]Yahoo! Finance
- Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024GlobeNewswire
EKSO
Earnings
- 4/29/24 - Miss
EKSO
Sec Filings
- 4/29/24 - Form 10-Q
- 4/29/24 - Form 8-K
- 4/26/24 - Form ARS
- EKSO's page on the SEC website